The Oncology Institute, Inc. (TOI)
After hours:
| Previous Close | 0.6732 |
| Open | 0.6859 |
| Bid | 0.5923 x 100 |
| Ask | 0.6679 x 100 |
| Day's Range | 0.6202 - 0.6970 |
| 52 Week Range | 0.3300 - 2.6550 |
| Volume | |
| Avg. Volume | 140,567 |
| Market Cap | 47.486M |
| Beta (5Y Monthly) | 0.83 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.9200 |
| Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.00 |
- GuruFocus.com
The Oncology Institute Inc (TOI) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
TOI reports a robust revenue increase and strategic expansions, counterbalanced by margin pressures and operational losses in the first quarter of 2024.
GlobeNewswireThe Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance
CERRITOS, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended March 31, 2024. Recent Operational Highlights Include: Successfully completed integration of first capitated risk contract direct to a health plan, and launched MSO model to enhance employed clinic locations, in the Florida market, effective
- GlobeNewswire
The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit
CERRITOS, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate in the “Defining the Next Chapter in Value-Based Care” panel at the Leerink Healthcare Transformation Summit in Montecito at 8:30am ET on May 16, 2024. About The Oncology Institute, Inc. Founded in 2007, The Oncology Institute, Inc. and its affiliate
